Matrix metalloproteinase-2 (-1306 C>T) promoter polymorphism and risk of colorectal cancer in the saudi population

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 6025-6030

  Saeed, Hesham Mahmoud ^a,b,d,e   Alanazi, Mohammad Saud ^a,d,e   Parine, Narasimha Reddy ^a,d,e   Shaik, Jilani ^a,d,e   Semlali, Abdelhabib ^a,d,e   Alharbi, Othman ^a,d,e   Azzam, Nahla ^a,d,e   Aljebreen, Abdulrahman ^a,d,e   Almadi, Majid ^a,d,e   Shalaby, Manal Aly ^a,c,d,e  

^a University Hospital   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e Universities and Research Institutes District   (Egypt)

Author keywords

Colorectal cancer; Matrix metalloproteinases; Odds ratios; ORs; Single nucleotide polymorphism

Indexed keywords

DNA; GELATINASE A; MMP2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL CULTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; SAUDI ARABIA; TUMOR CELLS, CULTURED;

EID: 84890464844     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.6025     Document Type: Article

References (38)

1. Ajay G, Boland CR (2012). Reviews in basic and clinical gastroenterology and hepatology. Gastroenterol, 143, 1442-60.
2. Alory I, Soussan L, Seger R, Yarden Y (1999). Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol Cell Biol, 19, 1961-72.
3. Block KL, Shou Y, Poncz M (1996). An Ets/Sp1 interaction in the 5'-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood, 88, 2071-80.
4. Boag AH, Young ID (1994). Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am J Pathol, 144, 585-91.
5. Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe. Ann Oncol, 16, 481-8.
6. Clifford A, Beeuwkes R, Lainey L, Silverman KJ (1984). Hypothesis: vasa vasorum and neovascularization of human coronary arteries, a possible role in the pathophysiology of atherosclerosis. N Engl J Med, 310, 175-7.
7. Collins HM, Morris TM, Watson SA (2001). Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1 matrix metalloproteinase. Br J Cancer, 84, 1664-70.
8. Elander N, Soderkvist P, Fransen K (2006). Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res, 26, 791-5.
9. Enping X, Maode L, Bingjian L, et al (2004). A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun, 324, 999-1003.
10. Fang, J, Shing Y, Wiederschain D, et al (2000). Matrix metalloproteinase-2 required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA, 97, 3884-9.
11. Flavia MG, Alisson MO, Riccardo L, et al (2013). Matrix metalloproteinase (MMP-2) gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura. Gene, 512, 35-40.
12. Gail W, Kevan H (2012). Clinical Update: colon, rectal, and anal cancers. Seminars in Oncology Nursing, 28, 1-22.
13. Grieu F, Li WQ, Iacopetta B (2004). Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat, 8, 197-204.
14. Heavey PM, McKenna D, Rowland IR (2004). Colorectal cancer and relationship between genes and the environment. Nutr Cancer, 48, 124-41.
15. Hemminki K, Czene K (2002). Attributable risk of familial cancer from the family cancer database. Cancer Epidemiol Biomarkers Prev, 12, 1638-44.
16. Itoh T, Tanioka M, Yoshida H, et al (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res, 58, 1048-51.
17. Jormsjo S, Ye S, Moritz J, et al (2000). Allele specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res, 86, 998-1003.
18. Laurie AS, Sandra JT, William GS (2012). Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol, 181, 1895-9.
19. Lionel L, Abdelhabib S, Marc B, et al (2010). Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/a5β1 interaction. Mol Immunol, 47, 2112-8.
20. Loubaki L, Semlali A, Boisvert M, et al (2010). Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/a5β1 interaction. Mol Immunol, 47, 2112-8.
21. Margana RK, Boggaram V (1997). Functional analysis of surfactant protein B (SP-B) promoter:Sp1, Sp3, TTF-1, and HNF-3a transcription factors are necessary for lung cell-specific activation of SP-B gene transcription. J Biol Chem, 272, 3083-90.
22. Maouche L, Lucien N, Cartron JP, Chretien S (1995). A CCACC motif mediates negative transcriptional regulation of the human erythropoietin receptor. Eur J Biochem, 233, 793-9.
23. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108.
24. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al (1992). Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol, 141, 389-96.
25. Potter JD (1999). Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916-32.
26. Price SJ, Greaves DR, Watkins H (2001). Identification of novel functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele specific transcriptional regulation. J Biol Chem, 276, 7549-58.
27. Priyanka S, Tasleem AL, Rakesh K, Rama DM (2012). Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in north India. Arch Med Res, 43, 117-24.
28. Qin H, Sun Y, Benveniste EN (1999). The transcription factor Sp1, Sp3 and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem, 274, 29130-7.
29. Roehe AV, Frazzon AP, Agnes G, et al (2007). Detection ofpolymorphisms in the promoter of matrix metalloproteinase 2 and 9 genes in breast cancer in South Brazil: preliminary results. Breast Cancer Res Treat, 102, 123-4.
30. Rutter JL, Mitchell TI, Buttice G, et al (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res, 58, 5321-5.
31. Sanger F, Nicklen S, Coulson A (1977). DNA sequencing with chain terminating inhibitor. Proc Natl Acad Sci USA, 74, 5463-7.
32. Simon JP, David RG, Hugh W (2001). Identification of novel, functional genetic variants in the Human matrix metalloproteinase-2 gene. J Biol Chem, 276, 7549-58.
33. Singer CF, Marbaix E, Kokorine I, et al (1997). Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1 alpha and its dual block by ovarian steroids. Proc Natl Acad Sci (USA), 94, 10341-5.
34. Strongin AY, Collier I, Bannikov G, et al (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J Biol Chem, 270, 5331-8.
35. Woessner JF (1998). In Matrix metalloproteinases (Parks, W.C., and Mecham, R.P., eds) pp. 1-14, Academic Press, Inc., San Diego, CA.
36. Yihong H, Li S, Naqiong W, et al (2009). Polymorphisms of MMP-2 gene are associated with systolic heart failure prognosis. Clin Chim Acta, 404, 119-23.
37. Yrjö TK, Mia A, Heikki V, et al (1999). Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis, 58, 691-7.
38. Zhou Y, Yu C, Miao X, et al (2004). Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitors of the matrix metalloproteinase-2 genes. Carcinogenesis, 25, 399-404.